The personnel of the pharmaceutical company changed, and another deputy general manager resigned

Fuxiang Pharmaceutical recently announced that the company's board of directors received a written resignation report from Huang Xiaodong, deputy general manager and board secretary on February 14, 2022.
Huang Xiaodong resigned from the company's deputy general manager and board secretary due to personal reasons.
hold any position in the company
.
According to public information, Huang Xiaodong joined Fuxiang Pharmaceutical in June 2016 as the secretary of the board of directors and deputy general manager
.
Previously, he worked as a senior executive of Ren Anbang, Xinhua Online, Ren Rongda Finance and other companies
.
As of the disclosure date of Huang Xiaodong's resignation report, he directly held 115,200 shares of Fuxiang Pharmaceutical, and indirectly held 75,000 shares through the company's "First Phase Employee Stock Ownership Plan (Draft)"
.
Since 2022, due to the influence of the medical environment, personnel changes in the industry are still frequent
.
According to the author's incomplete statistics, more than 10 deputy general managers of pharmaceutical companies have resigned during the year, involving Xinlitai, Huayuan Bio, Zixin Pharmaceutical, Jiuqiang Bio, Ruipu Bio, Harbin Pharmaceutical Co.
, Ltd.
, Sunshine Guojian,
etc.
On February 7, Xinlitai announced that the company recently received a written resignation report submitted by Zhu Meixia, the company's deputy general manager
.
Zhu Meixia applied to resign from the position of deputy general manager of the company because she had reached the retirement age
.
After the resignation takes effect, he will no longer hold any position in the company
.
On January 28, Garden Biology issued an announcement that Mr.
Chen Yi, the company's deputy general manager, recently applied to the company's board of directors to resign as the company's deputy general manager because he has reached the retirement age
.
After Mr.
Chen Yi resigned as the deputy general manager of the company, he continued to hold other positions in the company
.
On January 22, Zixin Pharmaceutical announced that the company's board of directors received a resignation report submitted by the company's deputy general manager and board secretary Zhang Wanheng on January 21, 2022
.
Zhang Wanheng resigned from the company's deputy general manager and board secretary due to job transfer.
After his resignation, Zhang Wanheng will no longer hold a position in the company
.
On January 21, Jiuqiang Bio announced that Mr.
Xue Yuwei had applied to resign as the company's deputy general manager because he had reached the retirement age
.
After he resigned as the deputy general manager of the company, he continued to hold other positions in the company
.
On January 14, Ruipu Biotech announced that Mr.
Liu Juhong applied for his resignation as the deputy general manager of the company due to personal reasons.
After Mr.
Liu Juhong resigned, he would no longer hold any positions in the company
.
On January 13, Harbin Pharmaceutical announced that Mr.
Wang Penghao resigned from the position of deputy general manager of the company due to personal reasons, and would no longer hold any other positions in the company after his resignation
.
On the same day, Sunshine Guojian announced that Mr.
ZHU ZHENPING applied for his resignation as a non-independent director/deputy general manager/head of R&D of the fourth board of directors of the company due to work adjustment, and will no longer hold any positions in the company after his resignation
.
On January 7, Sinopharm announced that due to personal reasons, Ms.
Zhu Lin will no longer serve as the secretary of the company's board of directors and the company's deputy general manager
.
On January 6, Shengxiang Bio announced that Mr.
Gui Yaokui had applied for his resignation as the company's deputy general manager due to personal reasons, and he would no longer hold any positions in the company after his resignation
.
On January 5, Bloomage Bio announced that due to personal reasons, Mr.
Li Huiliang resigned as the company's deputy general manager and chief technical officer, and no longer served as a core technician.
After his resignation, he will no longer hold any positions in the company and its subsidiaries.

.
On January 4, Tigermed announced that Wang Ruwei had applied for his resignation as the company's deputy general manager due to job transfer
.
After Wang Ruwei resigned as the company's deputy general manager, he still held other positions in the company's subsidiaries
.
From the above reasons, most of the deputy general managers resigned due to personal reasons and job adjustment
.
At present, the entire pharmaceutical market environment is changing, driving personnel changes frequently, and the industry expects that the wave of departures in the pharmaceutical industry will continue in the future
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.